Skip to content
Clinical Trials – home
IcelandBack to Iceland

Clinical trials in Reykjavik

27 clinical trials in Reykjavik, Iceland. Every trial is listed in the EU Clinical Trials Register and updated daily.

IcelandOur site in IcelandKliniskarRannsoknir.is(opens in a new tab)
Reykjavik at a glance
27
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

27 trials in Reykjavik

Open in trial search
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Karolinska University Hospital
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Dalteparin Sodium
  • Sponsor:Rigshospitalet
Registered drug
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Aarhus Universitet
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Karolinska Institutet
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Aficamten
  • Sponsor:Cytokinetics Inc.
Countries:IcelandIceland
  • Participants:0–17 years · 18–64 years
  • Substances:Cytarabine
  • Sponsor:Princess Maxima Center For Pediatric Oncology
Countries:IcelandIceland
  • Participants:0–17 years · 18–64 years
  • Substances:Quizartinib Dihydrochloride
  • Sponsor:Princess Maxima Center For Pediatric Oncology
Registered drug
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska University Hospital
Countries:IcelandIceland
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Karolinska University Hospital
Countries:IcelandIceland
  • Participants:18–64 years
  • Substances:Nivolumab
  • Sponsor:Region Midtjylland

Dyspepsia

Not yet recruiting
Registered drug
Countries:IcelandIceland
  • Participants:18–64 years
  • Substances:Calcium Carbonate
  • Sponsor:Landspitali

Other cities in Iceland

The busiest research cities in the country

All 2 cities in Iceland

Clinical research in Reykjavik

What the registry says about research in the country

01 Cardiovascular Research

Innovative trials exploring treatments for cardiovascular diseases, including studies on lipoprotein reduction and atherosclerosis prevention. Research focuses on reducing major cardiovascular events in high-risk patients.

  • Atherosclerotic Disease Management
  • Hypertrophic Cardiomyopathy
  • Post-Bypass Treatment Strategies

Studies aim to improve patient outcomes through targeted therapeutic approaches and preventive measures.

02 Oncology Studies

Comprehensive research into various cancer types, including lymphoma, breast cancer, and lung cancer treatments. Trials evaluate novel therapeutic combinations and targeted approaches.

  • Bladder Cancer Treatments
  • Multiple Myeloma Management
  • Advanced Lung Cancer Therapy

Focus on improving survival rates and developing more effective treatment protocols.

03 Hematology Research

Advanced studies in blood disorders, particularly focusing on acute myeloid leukemia and lymphoblastic leukemia. Specialized treatments for both adult and pediatric patients.

  • Pediatric Leukemia Protocols
  • Novel Immunotherapy Approaches
  • Targeted Molecular Therapies

Emphasis on improving survival rates and developing personalized treatment strategies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).